Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.
Based in
Meise
Tags
Biotechnology, Therapeutics
Total Funding
Between €5 million-€10 million
Founded
2020
Website
montisbiosciences.com/
💡 You're a corporate or investor and looking for startups that are innovating in the same market as Montis Biosciences? We're happy to assist you with our Startup Sourcing service.